TIL for the treatment of patients with solid cancer: an interactive workshop

Personalised T-cell therapy has now reached the solid tumour therapy field as a first of-its-kind immunotherapy for patients with melanoma with an approval granted by the FDA on February 17th, 2024.

Os cancros tornam-se resistentes à quimioterapia principalmente de duas formas. Ou têm uma resistência pré-existente a um tipo de medicamento ou desenvolvem resistência através de mutações.

Eis algumas das principais razões para o surgimento da resistência aos medicamentos contra o cancro. 

The Champalimaud Foundation is looking for Anatomical Pathology Technicians to be part of the Pathology Department team.

Duration

The position has an initial duration of 12 months.

Position

The selected candidates will be part of the technical team of the Anatomic Pathology Service and will work in gross examination, histology, cytology, ancillary techniques, and other laboratory tasks.